Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story

Shelley Wood

November 30, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Presentation TCT 2022

The Importance of Pre-emptive TAVR in the Future Management of Aortic Stenosis

Presenter: Philippe Genereux

September 19, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

How Will Emerging Evidence Help Us?

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

OpSens SavvyWire: Device Review & Case Example

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Assembling the Safest Solution for Hemodynamic Support in Heart Failure (Puzzle Medical)

Presenter: Philippe Genereux

September 17, 2022

Presentation TCT 2022

Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier?

Presenter: Philippe Genereux

September 17, 2022

News Daily News

Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis

L.A. McKeown

August 09, 2022

Presentation TVT 2022

Bleeding Detection During Large Bore Procedure: The Saranas Bleeding Detection System

Presenter: Philippe Genereux

June 10, 2022

Presentation TVT 2022

Left Ventricle Pacing AND Gradient Monitoring During TAVR: The OpSens SAVVY Wire

Presenter: Philippe Genereux

June 10, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

Partner Content

Lifetime Patient Management and the Importance of TAVR Hemodynamics

October 27, 2022

Advertisement

TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Valve Fracture for ViV TAVI Linked With Higher Mortality

The Importance of Pre-emptive TAVR in the Future Management of Aortic Stenosis

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

How Will Emerging Evidence Help Us?

OpSens SavvyWire: Device Review & Case Example

Assembling the Safest Solution for Hemodynamic Support in Heart Failure (Puzzle Medical)

Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier?

Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis

Bleeding Detection During Large Bore Procedure: The Saranas Bleeding Detection System

Left Ventricle Pacing AND Gradient Monitoring During TAVR: The OpSens SAVVY Wire

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Lifetime Patient Management and the Importance of TAVR Hemodynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content